Precigen, Inc.
PGEN
$3.71
$0.143.92%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 31.62M | 9.71M | 6.30M | 4.33M | 4.21M |
| Total Other Revenue | -23.00K | 0.00 | 35.00K | 36.00K | 15.00K |
| Total Revenue | 31.60M | 9.68M | 6.31M | 4.34M | 4.20M |
| Cost of Revenue | 31.75M | 35.13M | 39.47M | 38.44M | 38.82M |
| Gross Profit | -155.00K | -25.45M | -33.16M | -34.10M | -34.62M |
| SG&A Expenses | 78.82M | 70.13M | 63.48M | 49.33M | 43.50M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 121.59M | 116.28M | 113.98M | 98.79M | 97.09M |
| Operating Income | -90.00M | -106.60M | -107.67M | -94.45M | -92.89M |
| Income Before Tax | -204.42M | -250.64M | -246.95M | -124.57M | -158.41M |
| Income Tax Expenses | 3.00K | 3.00K | -84.00K | -72.00K | -1.76M |
| Earnings from Continuing Operations | -204.42 | -250.64 | -246.87 | -124.50 | -156.65 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -204.42M | -250.64M | -246.87M | -124.50M | -156.65M |
| EBIT | -90.00M | -106.60M | -107.67M | -94.45M | -92.89M |
| EBITDA | -86.33M | -103.40M | -104.95M | -91.86M | -89.33M |
| EPS Basic | -1.24 | -1.40 | -1.40 | -0.43 | -0.57 |
| Normalized Basic EPS | -0.40 | -0.50 | -0.51 | -0.27 | -0.28 |
| EPS Diluted | -1.24 | -1.40 | -1.40 | -0.43 | -0.57 |
| Normalized Diluted EPS | -0.40 | -0.50 | -0.51 | -0.27 | -0.28 |
| Average Basic Shares Outstanding | 1.31B | 1.25B | 1.19B | 1.16B | 1.12B |
| Average Diluted Shares Outstanding | 1.31B | 1.25B | 1.19B | 1.16B | 1.12B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |